In TRIUMPH-4, participants with obesity and knee osteoarthritis taking retatrutide 12 mg lost ~28.7% of body weight (~71 lbs at 68 weeks) and saw substantial improvements in pain and function: WOMAC pain scores reduced by 4.5 points (75.8%) Meaningful gains in physical function, with many patients essentially free of knee pain by study end If these results are confirmed in broader use, were not just talking about weight loss drugs anymorewere talking about disease-modifying therapies that simultaneously target obesity, pain, mobility, and downstream CV risk
How To Prepare For Your Fit Retl fitters are everywherein bike shops, sports medicine clinics and individual fit studios
Abstract Glucagon-like petide-1 (GLP-1) potentiates insulin and suppresses glucagon secretion from the pancreas in response to the ingestion of nutrients
FDA-registered compounding pharmacies must follow strict pharmaceutical manufacturing requirements, pharmaceutical-grade semaglutide (the active ingredient) costs the same whether used in brand-name or compounded preparations, and testing for potency, sterility, and stability follows the same standards
